83 related articles for article (PubMed ID: 10970927)
1. Effects of divalproex versus lithium on length of hospital stay among patients with bipolar disorder.
Dalkilic A; Diaz E; Baker CB; Pearsall HR; Woods SW
Psychiatr Serv; 2000 Sep; 51(9):1184-6. PubMed ID: 10970927
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of divalproex versus lithium.
Baker CB; Woods SW; Sernyak MJ
J Clin Psychiatry; 1997 Aug; 58(8):363-4. PubMed ID: 9515977
[No Abstract] [Full Text] [Related]
4. The relationship between antimanic agent for treatment of classic or dysphoric mania and length of hospital stay.
Frye MA; Altshuler LL; Szuba MP; Finch NN; Mintz J
J Clin Psychiatry; 1996 Jan; 57(1):17-21. PubMed ID: 8543542
[TBL] [Abstract][Full Text] [Related]
5. A pharmacoeconomic model of divalproex vs. lithium in the acute and prophylactic treatment of bipolar I disorder.
Keck PE; Nabulsi AA; Taylor JL; Henke CJ; Chmiel JJ; Stanton SP; Bennett JA
J Clin Psychiatry; 1996 May; 57(5):213-22. PubMed ID: 8626353
[TBL] [Abstract][Full Text] [Related]
6. [Prophylactic long-term therapy of affective disorders with lithium, valproic acid and carbamazepine--effectiveness and cost-effectiveness].
Roick C; Ahrens B; Becker T
Psychiatr Prax; 2001 Jul; 28 Suppl 1():S32-40. PubMed ID: 11533905
[TBL] [Abstract][Full Text] [Related]
7. Is divalproex a cost-effective alternative in the acute and prophylactic treatment of bipolar I disorder?
Dardennes RM; Even C
J Clin Psychiatry; 1997 Nov; 58(11):495-6. PubMed ID: 9413417
[No Abstract] [Full Text] [Related]
8. Pharmacoeconomic and health outcome comparison of lithium and divalproex in a VA geriatric nursing home population: influence of drug-related morbidity on total cost of treatment.
Conney J; Kaston B
Am J Manag Care; 1999 Feb; 5(2):197-204. PubMed ID: 10346515
[TBL] [Abstract][Full Text] [Related]
9. Service utilization and costs of olanzapine versus divalproex treatment for acute mania: results from a randomized, 47-week clinical trial.
Zhu B; Tunis SL; Zhao Z; Baker RW; Lage MJ; Shi L; Tohen M
Curr Med Res Opin; 2005 Apr; 21(4):555-64. PubMed ID: 15899104
[TBL] [Abstract][Full Text] [Related]
10. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
Yatham LN; Vieta E; Young AH; Möller HJ; Paulsson B; Vågerö M
Int Clin Psychopharmacol; 2007 Jul; 22(4):212-20. PubMed ID: 17519644
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of quetiapine with lithium or divalproex for maintenance treatment of bipolar I disorder.
Woodward TC; Tafesse E; Quon P; Kim J; Lazarus A
J Med Econ; 2009; 12(4):259-68. PubMed ID: 19769548
[TBL] [Abstract][Full Text] [Related]
12. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder.
Kowatch RA; Suppes T; Carmody TJ; Bucci JP; Hume JH; Kromelis M; Emslie GJ; Weinberg WA; Rush AJ
J Am Acad Child Adolesc Psychiatry; 2000 Jun; 39(6):713-20. PubMed ID: 10846305
[TBL] [Abstract][Full Text] [Related]
13. Pattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania.
Swann AC; Bowden CL; Calabrese JR; Dilsaver SC; Morris DD
Neuropsychopharmacology; 2002 Apr; 26(4):530-6. PubMed ID: 11927177
[TBL] [Abstract][Full Text] [Related]
14. Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium, or placebo.
Bowden CL; Collins MA; McElroy SL; Calabrese JR; Swann AC; Weisler RH; Wozniak PJ
Neuropsychopharmacology; 2005 Oct; 30(10):1932-9. PubMed ID: 15956987
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness of lurasidone as an adjunct to lithium or divalproex in the treatment of bipolar disorder.
Alamo C; López-Muñoz F; García-García P
Expert Rev Neurother; 2014 Jun; 14(6):593-605. PubMed ID: 24779382
[TBL] [Abstract][Full Text] [Related]
16. [Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine].
Dardennes R; Lafuma A; Watkins S
Encephale; 1999; 25(5):391-400. PubMed ID: 10598301
[TBL] [Abstract][Full Text] [Related]
17. Acute inpatient treatment, hospitalization course and direct costs in bipolar patients with intellectual disability.
Wu CS; Desarkar P; Palucka A; Lunsky Y; Liu SK
Res Dev Disabil; 2013 Nov; 34(11):4062-72. PubMed ID: 24051362
[TBL] [Abstract][Full Text] [Related]
18. Suicide risk in bipolar disorder during treatment with lithium and divalproex.
Goodwin FK; Fireman B; Simon GE; Hunkeler EM; Lee J; Revicki D
JAMA; 2003 Sep; 290(11):1467-73. PubMed ID: 13129986
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania.
Swann AC; Bowden CL; Calabrese JR; Dilsaver SC; Morris DD
Am J Psychiatry; 1999 Aug; 156(8):1264-6. PubMed ID: 10450271
[TBL] [Abstract][Full Text] [Related]
20. Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: analysis of two large randomized, placebo-controlled trials.
Suppes T; Vieta E; Gustafsson U; Ekholm B
Depress Anxiety; 2013 Nov; 30(11):1089-98. PubMed ID: 23761037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
